Explore 3 Stock Ideas & Industry Insights Download Free Report

Adia Nutrition Inc

Company price
0.124 USD 0.00(0%)
Last update at 2026-11-19T21:00:00Z
VOLUME
100
Market Cap
11.71M

Momentum Score

…

Adia Med Inc operates as a clinical-stage regenerative medicine company. The company offers products and services focused on stem cell therapies, regenerative medicine treatments, and clinical research in areas such as aesthetics, orthopedics, and autoimmune diseases. In addition, the company offers nutritional supplements and biologic products. It sells its products on a direct-to-consumer basis, as well as through other direct to consumer channels. The company was formerly known as Adia Nutrition, Inc. and changed its name to Adia Med Inc in June 2026. Adia Med Inc is based in Winter Park, Florida.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.12
Low
0.12
High
52 Week Price Range
0.03
Low
0.28
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Adia Nutrition Inc (OTCQB: ADIA) is an OTC-listed company described as operating in the nutrition/wellness sector, but public disclosures on products, customers and financials are limited. Its long-term outlook appears to depend on commercializing and scaling products, expanding distribution and meeting regulatory requirements; investors may value exposure to consumer health but face significant information gaps.

Key risks include limited disclosure and thin trading liquidity, small scale and execution risk, financing and dilution risk, and regulatory/product‑compliance uncertainty.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.12
Dividend Yield
-
Revenue TTM
1.17M
Revenue Per Share
0.01
Gross Profit TTM
0.49M
Debt / Equity
-1.67
ROE
-1460.81%
Net Debt
0.52M
ROCE
-81.51%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2004-12-31 2003-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2004-12-31 2003-12-31
Income before tax -0.40M -0.18M -0.00M -8.61M -0.60M
Minority interest - - - 0.00M 0.00M
Net income -0.40M -0.18M -0.00M -8.61M -0.60M
Selling general administrative 0.47M 0.18M 0.00M 4.30M 0.83M
Gross profit 0.19M 0.00M - 0.05M 0.33M
Reconciled depreciation 0.08M 0.01M - - -
Ebit - - - -6.04M -0.58M
Depreciation and amortization - - 0.00M - -
Non operating income net other - - - 0.00M 0.00M
Operating income -0.37M -0.17M -0.00M -6.04M -0.58M
Other operating expenses - - 0.00M 0.00M 0.00M
Interest expense 0.03M 0.01M - 0.00M 0.00M
Tax provision 0.00M 0.00M - - -
Interest income 0.00M 0.00M - - -
Net interest income -0.03M -0.01M - - -
Extraordinary items - - - 0.00M 0.00M
Non recurring - - - 0.00M 0.00M
Other items - - - 0.00M 0.00M
Income tax expense - - - 0.00M 0.00M
Total revenue 0.70M 0.01M - 0.20M 0.76M
Total operating expenses 1.07M 0.18M 0.00M 6.24M 1.34M
Cost of revenue 0.51M 0.00M - 0.15M 0.43M
Total other income expense net 0.00M - - -2.57M -0.02M
Discontinued operations - - - 0.00M 0.00M
Net income from continuing ops -0.40M -0.18M - -8.61M -0.60M
Net income applicable to common shares - - - -8.61M -0.60M
Preferred stock and other adjustments - - - 0.00M 0.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2004-12-31 2003-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2004-12-31 2003-12-31
Total assets 0.59M 0.67M 0.00M 2.99M 0.23M
Intangible assets - 0.01M - 0.93M 0.00M
Other current assets - - - 0.00M 0.00M
Total liab 0.85M 0.64M 0.00M 1.77M 0.39M
Total stockholder equity -0.26M 0.03M -0.00M 1.21M -0.17M
Deferred long term liab - - - 0.00M 0.05M
Other current liab - - - 0.05M 0.00M
Common stock - - 0.00M 0.02M 1.16M
Capital stock 0.10M 0.11M - - -
Retained earnings -15.97M -15.58M -0.02M -9.94M -1.33M
Other liab - - - 0.00M 0.00M
Good will - - - 1.05M 0.00M
Other assets - - - 0.03M 0.05M
Cash 0.08M 0.01M 0.00M 0.20M 0.10M
Total current liabilities 0.15M 0.08M 0.00M 1.39M 0.39M
Net debt 0.52M 0.36M 0.00M - -
Short term debt - - 0.00M 0.00M 0.00M
Short long term debt - - - 0.00M 0.00M
Short long term debt total - - 0.00M - -
Other stockholder equity - - 0.02M -0.01M 0.00M
Property plant equipment - - - 0.60M 0.03M
Total current assets 0.16M 0.26M 0.00M 0.37M 0.14M
Long term investments 0.08M 0.08M - 0.00M 0.00M
Net tangible assets - - - -0.77M -0.17M
Short term investments - - - 0.00M 0.00M
Net receivables 0.03M 0.00M - 0.10M 0.03M
Long term debt 0.60M 0.37M - 0.00M 0.00M
Inventory 0.03M 0.07M - 0.00M 0.00M
Accounts payable 0.00M 0.00M - 0.66M 0.04M
Total permanent equity - - - 0.00M 0.00M
Noncontrolling interest in consolidated entity - - - 0.00M 0.00M
Temporary equity redeemable noncontrolling interests - - - 0.00M 0.00M
Accumulated other comprehensive income - - 0.00M 0.00M 0.00M
Additional paid in capital - - - 0.00M 0.00M
Common stock total equity - - - 0.00M 0.00M
Preferred stock total equity - - - 0.00M 0.00M
Retained earnings total equity - - - 0.00M 0.00M
Treasury stock - - - 0.00M 0.00M
Accumulated amortization - - - 0.00M 0.00M
Non currrent assets other - - - 0.00M 0.00M
Deferred long term asset charges - - - 0.00M 0.00M
Non current assets total 0.43M 0.41M - 0.00M 0.00M
Capital lease obligations 0.20M 0.26M - 0.00M 0.00M
Long term debt total - - - 0.00M 0.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2004-12-31 2003-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2004-12-31 2003-12-31
Investments - - - 0.00M 0.00M
Change to liabilities - - - 0.63M 0.01M
Total cashflows from investing activities - - - -0.17M -0.03M
Net borrowings 0.21M 0.34M - -0.01M 0.01M
Total cash from financing activities 0.28M 0.37M 0.00M 4.19M 0.29M
Change to operating activities - - - 0.01M 0.06M
Net income -0.40M -0.18M -0.00M -8.61M -0.60M
Change in cash 0.07M 0.01M 0.00M 0.10M -0.02M
Begin period cash flow 0.01M 0.00M - - -
End period cash flow 0.08M 0.01M 0.00M - -
Total cash from operating activities -0.18M -0.34M -0.00M -3.92M -0.29M
Issuance of capital stock 0.07M 0.03M - - -
Depreciation 0.08M 0.01M - 0.12M 0.02M
Other cashflows from investing activities - - - -0.10M -0.10M
Dividends paid - - - 0.00M 0.00M
Change to inventory -0.03M -0.14M - 0.00M 0.00M
Change to account receivables -0.03M 0.00M - -0.07M 0.04M
Sale purchase of stock - - - 0.00M 0.00M
Other cashflows from financing activities - - 0.00M 0.05M 0.05M
Change to netincome - - - 3.89M 0.19M
Capital expenditures 0.01M 0.03M 0.00M 0.07M 0.03M
Change receivables - - - 0.00M 0.00M
Cash flows other operating - - - 0.00M 0.00M
Exchange rate changes - - - 0.00M 0.00M
Cash and cash equivalents changes - - - 0.00M 0.00M
Change in working capital 0.10M -0.19M - - -
Stock based compensation 0.04M 0.03M - - -
Free cash flow -0.19M -0.36M -0.00M - -

Peer Comparison*

Sector: Healthcare Industry: Medical Care Facilities

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
ADIA
Adia Nutrition Inc
-
-%
0.12 - - 9.99 - 10.48
HCA
HCA Healthcare, Inc.
15.19
3.30%
475.52 14.27 13.46 1.21 291.34 1.83
THC
Tenet Healthcare Corporation
-0.10
0.04%
263.49 10.08 12.66 0.96 4.57 1.43
FSNUY
Fresenius SE & Co KGaA ADR
-0.22
1.52%
14.00 16.87 9.44 0.42 0.78 0.79
JDHIY
JD Health International Inc
1.31
30.75%
5.57 62.50 35.97 0.30 2.32 0.16

Profile*

Adia Nutrition Inc

Adia Med Inc operates as a clinical-stage regenerative medicine company. The company offers products and services focused on stem cell therapies, regenerative medicine treatments, and clinical research in areas such as aesthetics, orthopedics, and autoimmune diseases. In addition, the company offers nutritional supplements and biologic products. It sells its products on a direct-to-consumer basis, as well as through other direct to consumer channels. The company was formerly known as Adia Nutrition, Inc. and changed its name to Adia Med Inc in June 2026. Adia Med Inc is based in Winter Park, Florida.

1561 West Fairbanks Avenue, Winter Park, FL, United States, 32789

321-231-2843

3

Name Title Year Born
Mr. Bill Hodson CEO & Director 1967
Ms. - Jenny Co-Founder NA
Ms. - April Co-Founder NA
Mr. Todd Smith Head of Strategic Marketing Team NA
Mr. Larry Powalisz CEO, President, Secretary & Director 1964
Ms. Rebecca Miller Chief Financial Officer 1976
Mr. Larry Powalisz CEO, President, Secretary & Chairman 1964
Ms. Jenny Angeloff Singhal Co-Founder NA
Ms. April Nugent Co-Founder NA
Ms. Dawn Bell Chief Revenue Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…